Vitamins China E-News

Publication: Monthly on the
Published by CCM

Vitamins China E-News provides you with real-time intelligence on China's vitamins market.
 
China is the world's largest exporter of vitamins, while the domestic market has also expanded rapidly in recent years thanks to growing demand from the feed and pharmaceuticals markets. Now, competition in the industry is shifting from producing API to higher-margin pharmaceutical-grade products, while China’s tougher stance on environmental protection is also having an effect.
 
Vitamins China E-News will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire vitamins industry chain, from raw materials to end consumption. This includes:
      
  • Breaking news from China and abroad
  •   
  • The latest market data, including price information for raw materials, intermediates and end products, import/export data, production, consumption, operating rates, etc.
  •   
  • In-depth analysis of market trends, Chinese government policy, the performance of leading Chinese producers, M&A, new technologies, and more
  •   
  • Expert commentary from industry insiders, including regular guest articles and interviews with insiders at leading Chinese manufacturers, associations and government organizations
Vitamins China E-News is also available as a monthly newsletter, which can be downloaded in PDF format. For more information, you can download a free sample below, or get in touch with us directly by emailing econtact@cnchemicals.com or calling +86-20-37616606.


  • Future-issues subscription

Starting from the issue of
202403
lasting for


0.5 1 1.5 2 2.5 3


year(s)  , is priced at


  • Single user license:
    USD 2,950
  • Corporate license:
    USD 7,375

All the prices on this website exclude VAT.

<<
  • 202403
  • 202402
  • 202401
  • 202312
  • 202311
  • 202310
  • 202309
  • 202308
  • 202307
  • 202306
  • 202305
  • 202304
  • 202303
  • 202302
  • 202301
  • 202212
  • 202211
  • 202210
  • 202209
  • 202208
  • 202207
  • 202206
  • 202205
  • 202204
  • 202203
  • 202202
  • 202201
  • 202112
  • 202111
  • 202110
  • 202109
  • 202108
  • 202107
  • 202106
  • 202105
  • 202104
  • 202103
  • 202102
  • 202101
  • 202012
  • 202011
  • 202010
  • 202009
  • 202008
  • 202007
  • 202006
  • 202005
  • 202004
  • 202003
  • 202002
  • 202001
  • 201912
  • 201911
  • 201910
  • 201909
  • 201908
  • 201907
  • 201906
  • 201905
  • 201904
  • 201903
  • 201902
  • 201901
  • 201812
  • 201811
  • 201810
  • 201809
  • 201808
  • 201807
  • 201806
  • 201805
  • 201804
  • 201803
  • 201802
  • 201801
  • 201712
  • 201711
  • 201710
  • 201709
  • 201708
  • 201707
  • 201706
  • 201705
  • 201704
  • 201703
  • 201702
  • 201701
  • 201612
  • 201611
  • 201610
  • 201609
  • 201608
  • 201607
  • 201606
  • 201605
  • 201604
  • 201603
  • 201602
  • 201601
  • 201512
  • 201511
  • 201510
  • 201509
  • 201508
  • 201507
  • 201506
  • 201505
  • 201504
  • 201503
  • 201502
  • 201501
  • 201412
  • 201411
  • 201410
>>

Main Content of Vitamins China E-News 202005

Price of this issue :
USD 123

Published on 29th May, 2020

On 27 April, the National Medical Products Administration issued an announcement to convert VC chewable tablet (50mg) and other seven drugs to OTC drugs from Rx drugs. In respond to this, relevant enterprises shall submit the supplementary application of revising specification to the drugs regulatory department for filing before 26 Jan., 2021.

Published on 29th May, 2020

Due to the increasing costs in raw material and India's lockdown, domestic large-scale VB3 producers successively raised their quotations since Jan. 2020. The price hike in May was slightly sharper than that a month ago.

Published on 26th May, 2020

Published on 22nd May, 2020

On 28 April, Weixinkang Medicine announced that it planned to terminate its oral preparation of certain factor Xa inhibitor chemical drugs (APIs and TAs) project and instead inject the surplus funds into its glycocholic acid project.

Published on 21st May, 2020

On 6 May, Jiande Sub-bureau of Hangzhou Ecology and Environment Bureau proposed to approve and publish Gongnengtai Biotechnology's 14,550 t/a feed additive and 50 t/a food additive project.

Published on 20th May, 2020

China's vitamin exports saw increases in March. Compared with exports in Jan.–Feb. 2020 and in March 2019, March 2020 has witnessed increases both in export volume and amount.

Published on 18th May, 2020

Published on 16th May, 2020

A-share listed vitamin companies released their performances for Q1 at the end of April. Among the eight surveyed companies, four of them saw YoY increases both in revenues and profits. However, affected by the COVID-19 epidemic, Guangji Pharmaceutical experienced decreases both in revenues and profits.

Published on 15th May, 2020

Published on 15th May, 2020

Zhejiang Medicine issued a notice on 25 April that it planned to relocate Xinchang Pharmaceutical Factory's capacity to Keming Biomedicine, a new production base registered by Zhejiang Medicine on 19 Dec., 2019.

Published on 14th May, 2020

Published on 13th May, 2020

Published on 13th May, 2020

Published on 12th May, 2020

Published on 12th May, 2020

Published on 11th May, 2020

Published on 9th May, 2020

Qianjiang Biochemical noted on its 2019 annual report that the company added "feed additive—— riboflavin (vitamin B2)" to its main products, and removed "veterinary drug feed additive——colistin sulfate TC and formulation". Meanwhile, the company has resumed feed additive vitamin B2's production and sold it on a small scale.

Published on 8th May, 2020

Published on 8th May, 2020

Yangcheng Biotech's 800 t/a &gamma;-aminobutyric acid and 1,000 t/a D-calcium pantothenate project passed protection acceptance publicity and its deadline for its acceptance monitoring report was on 6 May, 2020.

Published on 7th May, 2020

In late April, Brother Enterprises announced to approve the Proposal to Invest in the Construction of 13,000 t/a Vitamin B3, 3,000 t/a Spice and Intermediate Project, which will be undertaken by Brother Pharmaceutical.

Published on 7th May, 2020

Published on 7th May, 2020

Published on 7th May, 2020


CCM Customized Service on Market Research

Do you want Import & Export Analysis, Financial Data, Cost Analysis, Supply Chain Research etc. ? We will customize the specific research for you, in case the services listed above does not meet your precise requirements. Our product and industry research in China’s agriculture, chemicals, food & ingredients and life science markets will comprehensively cover the business information, which is able to help you arrive at strategic and profitable business decisions.

Please directly contact econtact@cnchemicals.com to specify your Market Research Requirement